We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current RADCQ market cap is 1.13M. The company's latest EPS is USD -13.2632 and P/E is -0.05.
| Year End 04 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 21.64B | 21.93B | 24.04B | 24.57B | 24.09B |
| Operating Income | -291.21M | 139.42M | 17.29M | -156.38M | -469.35M |
| Net Income | -422.21M | -452.17M | -90.91M | -538.48M | -749.94M |
| Year End 04 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.59B | 9.45B | 9.34B | 8.53B | 7.53B |
| Total Liabilities | 6.4B | 8.78B | 8.72B | 8.43B | 8.17B |
| Total Equity | 1.19B | 674.53M | 615.15M | 99.03M | -641.78M |
| Year End 04 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -228.67M | 487.02M | 22.99M | 379.27M | -52.44M |
| Investing | 466.19M | -86.54M | -15.03M | -134.07M | -104.76M |
| Financing | -540.5M | -326.65M | -65.24M | -366.38M | 274.63M |
| Market Cap | 1.13M |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.23 |
| Price to Book Ratio | -0.06 |
| Dividend Yield | - |
| Shares Outstanding | 56.54M |
| Average Volume (1 week) | 13.52k |
| Average Volume (1 Month) | 35.61k |
| 52 Week Change | -90.00% |
| 52 Week High | 0.51 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Rite Aid Corporation (CE) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.riteaid.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
